Related Experiment Video

Updated: Aug 22, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

State of the science for care of older adults with heart disease

Christi Deaton1, Jill A Bennett, Barbara Riegel

  • 1School of Nursing, Midwifery & Health Visiting, University of Manchester, Coupland 3, Coupland Street, Manchester M13 9PL, United Kingdom. mary.c.deaton@man.ac.uk

The Nursing Clinics of North America
|August 28, 2004
PubMed

Insights

Research on cardiovascular disease in elders is crucial. While older adults are included in trials, specific studies on therapy safety and effectiveness in this population are essential.

Area of Science:

  • Gerontology
  • Cardiology
  • Clinical Research

Background:

  • Cardiovascular disease (CVD) is a significant health concern in the elderly population.
  • Coronary heart disease (CHD) and heart failure (HF) are prevalent diagnoses among older adults.
  • Existing research increasingly includes older patients, but specific data for this demographic is limited.

Purpose of the Study:

  • To provide an overview of current knowledge regarding cardiovascular disease in elders.
  • To highlight the need for targeted research on therapies for older individuals.
  • To emphasize the necessity of evaluating safety, efficacy, and acceptability of treatments in the oldest old.

Main Methods:

  • Literature review and synthesis of existing research on CVD in elders.
  • Focus on common cardiovascular conditions like CHD and HF in older populations.
  • Analysis of current trial inclusion criteria and research gaps.

Main Results:

  • Older adults are increasingly represented in clinical trials for cardiovascular conditions.
  • A significant gap exists in research specifically testing known therapies in older patients.
  • There is a critical need for studies evaluating the safety, efficacy, and acceptability of therapies in the oldest old.

Conclusions:

  • Despite increased inclusion in trials, dedicated research on cardiovascular therapies for elders is essential.
  • Further investigation is required to understand the unique needs and responses of the oldest old to treatments.
  • Future research should prioritize safety, efficacy, and acceptability studies tailored to geriatric cardiovascular patients.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...